Are These Stocks Primed To Climb? DNA Brands, Inc.(OTCMKTS:DNAX) and Baxano Surgical Inc(NASDAQ:BAXS)

Posted by admin August 13, 2014 0 Comment 972 views

New York, NY – 08/13/2014 –  HotStockGains provides investors  and traders with valuable trading strategies via text message and email. To join our free text message alerts service just text the word BREAKOUT to 555888 from your cell phone. Just text STOP to unsubscribe if you ever need to.

DNA Brands, Inc.(OTCMKTS:DNAX) saw its value increase by 23.53% during yesterday’s trading as the stock gained $0.0004 to finish the day at a closing price of $0.0021. Like most penny stocks, the company remains both heavily traded, with a daily volume of 150,599,416, and substantially below its 52 week high of seven cents. The Florida-based carbonated energy and coffee drinks producer, which employs just seven individuals on a full-time basis, currently has a market capitalization of $503,717.

            DNA Brands, which once traded for as much as $0.47 on Mar. 2nd, 2012, should be announcing its second quarter financial results by the midway point of the month of August. Nevertheless, the stock, whose three month average volume indicates that 18.8% of its total shares are traded on a daily basis, has remained below the one cent mark since spiking to $0.015 on Jun. 9Th, 2014.

Will DNA Brands Continue To See Its Value Rise? Click Here For A Free DNAX Analysis.

Baxano Surgical Inc(NASDAQ:BAXS) suffered a 6.09% decrease in value during yesterday’s trading as the stock lost $0.025 to close at $0.390. The stock notably traded for as little as $0.38 during the day, which represents a new 52 week low for the company that once traded for as much as $2.05. The North Carolina-based medical device company was also heavily traded: the stock had a trading volume of 530,442, a figure which is 213,655 above its three month average of 316,777.

On Aug. 5th, Baxano reported its second quarter financial results, which included a net loss per share of $0.12 and 20.1% increase in revenue. In response to its recent financial results, the company issued a third quarter total revenue guidance of $4.5 to $5 million. Baxano currently has a market capitalization of $18.95 million.

Does Baxano Surgical Have A Strong Outlook Despite Its Recent Losses? See Our Free BAXS Analysis.

About HotStockGains

I have a confession to make – I am not always right. Sometimes, unfortunately, I will send alerts that experience losses.

I have alerted companies that rallied 100% or even 6,000% (not even joking) in under a week. Likewise, I have alerted companies that tanked 10, 20, sometimes even as much as 30 or 40%. However overall it is about the net result that delivers profits into your portfolio.

Sign up for my free newsletter to receive market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks. If you are not satisfied, simply click unsubscribe.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit for complete risks and disclosures.

Write Your Comment